Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients
about
Importance of relating efficacy measures to unbound drug concentrations for anti-infective agentsIncrease of microcirculatory blood flow enhances penetration of ciprofloxacin into soft tissue.Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection.Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery.Blood, tissue, and intracellular concentrations of erythromycin and its metabolite anhydroerythromycin during and after therapyIssues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.Tissue pharmacokinetics of levofloxacin in human soft tissue infections.[18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans.Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues.Target site concentrations of ciprofloxacin after single intravenous and oral doses
P2860
Q26827380-F4132425-1E55-47DF-B44C-B9CED27A6936Q33224086-68044B8A-661F-4647-B25A-F97B0BAA92DFQ34077095-04AF47C7-13AD-44FD-8F31-C902FD20EBF0Q34510414-EA6E3601-0D93-4A10-BD78-70E0E1F88733Q35689377-08C33C02-7D81-4305-B10B-3EE6FF20B705Q35754443-CE6DB57B-F7BB-40AA-A576-9F4E5BD7DC1FQ35826148-BA014343-C0BD-4C2A-BF18-636DA9713C3DQ37568411-C76989B8-008B-410F-98CF-97D98C1CF7B3Q39475307-AE52EA30-E154-4879-BF25-DCC7EA6CF0BDQ39671107-36C9DD06-0AD6-4200-A0C2-2A374CBC2B3E
P2860
Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Penetration of ciprofloxacin i ...... ent diabetes mellitus patients
@ast
Penetration of ciprofloxacin i ...... ent diabetes mellitus patients
@en
type
label
Penetration of ciprofloxacin i ...... ent diabetes mellitus patients
@ast
Penetration of ciprofloxacin i ...... ent diabetes mellitus patients
@en
prefLabel
Penetration of ciprofloxacin i ...... ent diabetes mellitus patients
@ast
Penetration of ciprofloxacin i ...... ent diabetes mellitus patients
@en
P2093
P2860
P1476
Penetration of ciprofloxacin i ...... ent diabetes mellitus patients
@en
P2093
C Joukhadar
H Ehringer
H G Eichler
U Hollenstein
P2860
P304
P407
P577
1999-08-01T00:00:00Z